Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1960 1
1962 1
1963 4
1964 3
1965 2
1966 1
1967 1
1968 2
1969 5
1970 3
1971 4
1972 3
1973 3
1974 8
1975 9
1976 7
1977 8
1978 4
1979 9
1980 6
1981 14
1982 18
1983 19
1984 15
1985 23
1986 26
1987 40
1988 49
1989 55
1990 53
1991 49
1992 48
1993 71
1994 72
1995 76
1996 75
1997 85
1998 136
1999 109
2000 93
2001 117
2002 122
2003 91
2004 127
2005 128
2006 148
2007 161
2008 162
2009 150
2010 188
2011 173
2012 211
2013 292
2014 257
2015 225
2016 233
2017 257
2018 282
2019 253
2020 265
2021 280
2022 250
2023 224
2024 235
2025 254
2026 130

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,784 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kawashita y[au] (105 results)?
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Yamashita Y, et al. Circulation. 2023 Nov 21;148(21):1665-1676. doi: 10.1161/CIRCULATIONAHA.123.066360. Epub 2023 Aug 28. Circulation. 2023. PMID: 37638968 Free article. Clinical Trial.
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
Maura F, Bergsagel PL, Ziccheddu B, Kumar S, Maclachlan K, Derkach A, Garces JJ, Firestone R, Braggio E, Asmann Y, Durante M, Diamond BT, Papadimitriou M, Hultcrantz M, Marella A, Castellano G, Maeda A, Lionetti M, Matera A, Pioggia S, Da Vià MC, de Magistris C, Leongamornlert D, DeAvila D, Sudalagunta PR, Canevarolo RR, Siegel EM, Agius P, Teer J, McPherson A, Yamashita Y, Silva AS, Blaney P, Baz R, Patel KK, Campbell P, Morgan G, Fonseca R, Landgren O, Orlowski RZ, Shain KH, Bolli N, Usmani S, Rajkumar SV. Maura F, et al. Among authors: yamashita y. J Clin Oncol. 2026 Jan 20;44(3):188-199. doi: 10.1200/JCO-25-01733. Epub 2025 Oct 8. J Clin Oncol. 2026. PMID: 41061199 Free PMC article.
Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease.
Ito S, Taguchi K, Kodama G, Kubo S, Moriyama T, Yamashita Y, Yokota Y, Nakayama Y, Kaida Y, Shinohara M, Tashiro K, Ohta K, Yamagishi SI, Fukami K. Ito S, et al. Among authors: yamashita y. JCI Insight. 2025 May 22;10(13):e179362. doi: 10.1172/jci.insight.179362. eCollection 2025 Jul 8. JCI Insight. 2025. PMID: 40402578 Free PMC article. Clinical Trial.
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T; ONCO PE Trial Investigators. Yamashita Y, et al. Circulation. 2025 Mar 4;151(9):589-600. doi: 10.1161/CIRCULATIONAHA.124.072758. Epub 2024 Nov 18. Circulation. 2025. PMID: 39556015 Free PMC article. Clinical Trial.
Dynamic Flow-Assisted Nanoarchitectonics.
Ariga K, Fujioka S, Yamashita Y. Ariga K, et al. Among authors: yamashita y. ACS Appl Mater Interfaces. 2025 Apr 30;17(17):24778-24806. doi: 10.1021/acsami.5c03820. Epub 2025 Apr 21. ACS Appl Mater Interfaces. 2025. PMID: 40255047 Free PMC article. Review.
Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning.
Kawai M, Fukuda A, Otomo R, Obata S, Minaga K, Asada M, Umemura A, Uenoyama Y, Hieda N, Morita T, Minami R, Marui S, Yamauchi Y, Nakai Y, Takada Y, Ikuta K, Yoshioka T, Mizukoshi K, Iwane K, Yamakawa G, Namikawa M, Sono M, Nagao M, Maruno T, Nakanishi Y, Hirai M, Kanda N, Shio S, Itani T, Fujii S, Kimura T, Matsumura K, Ohana M, Yazumi S, Kawanami C, Yamashita Y, Marusawa H, Watanabe T, Ito Y, Kudo M, Seno H. Kawai M, et al. Among authors: yamashita y. Br J Cancer. 2024 Oct;131(7):1158-1168. doi: 10.1038/s41416-024-02794-5. Epub 2024 Aug 28. Br J Cancer. 2024. PMID: 39198617 Free PMC article.
FDX2, an iron-sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cells.
Miyahara S, Ohuchi M, Nomura M, Hashimoto E, Soga T, Saito R, Hayashi K, Sato T, Saito M, Yamashita Y, Shimada M, Yaegashi N, Yamada H, Tanuma N. Miyahara S, et al. Among authors: yamashita y. J Biol Chem. 2024 Sep;300(9):107678. doi: 10.1016/j.jbc.2024.107678. Epub 2024 Aug 14. J Biol Chem. 2024. PMID: 39151727 Free PMC article.
5,784 results